Titan Pharmaceuticals
Stock Forecast, Prediction & Price Target
Titan Pharmaceuticals Financial Estimates
Titan Pharmaceuticals Revenue Estimates
Titan Pharmaceuticals EBITDA Estimates
Titan Pharmaceuticals Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $1.52M N/A | $60K -96.06% | $184K 206.66% | Avg: $7.05M Low: $7.05M High: $7.05M avg. 3732.06% | Avg: $35.35M Low: $35.35M High: $35.35M avg. 401.38% | ||
Net Income
% change YoY
| $-8.11M N/A | $-10.17M -25.42% | $-5.56M 45.27% | Avg: $-6.46M Low: $-6.46M High: $-6.46M avg. -16.12% | Avg: $13.08M Low: $13.08M High: $13.08M avg. 302.32% | ||
EBITDA
% change YoY
| $-9.79M N/A | $-10.03M -2.50% | $-7.16M 28.62% | Avg: $-7.05M Low: $-7.05M High: $-7.05M avg. 1.59% | Avg: $-35.35M Low: $-35.35M High: $-35.35M avg. -401.38% | ||
EPS
% change YoY
| -$16.68 N/A | -$15.15 9.17% | -$7.41 51.08% | Avg: -$8.6 Low: -$8.6 High: -$8.6 avg. -16.05% | Avg: $17.4 Low: $17.4 High: $17.4 avg. 302.32% | ||
Operating Expenses
% change YoY
| $10.68M N/A | $10.29M -3.61% | $7.46M -27.52% | Avg: $194.43M Low: $194.43M High: $194.43M avg. 2506.08% | Avg: $974.90M Low: $974.90M High: $974.90M avg. 401.38% |
FAQ
What is Titan Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 143.09% in 2025-2026.
We have gathered data from N/A analysts. Their low estimate is -6.46M, average is -6.46M and high is -6.46M.
What is Titan Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 2066.72% in 2025-2026.
We have gathered data from 1 analysts. Their low revenue estimate is $7.05M, average is $7.05M and high is $7.05M.
What is Titan Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 143.13% in 2025-2026.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$8.6, average is -$8.6 and high is $-8.6.